Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...

[Andrew] had a case made by a local 3D printing ... big help to anyone trying to hack diabetes care. Until then, if you need a primer on continuous glucose monitoring, we’re happy to oblige.

Current glucose monitoring systems rely on enzymatic reactions to blood droplets, but those methods are not shelf-stable for ...

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

A research paper by scientists at The Second Affiliated Hospital of Zhejiang University School of Medicine presented the ...

Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and scientific fact-checking for the global public.

RUTHERFORD, N.J. and STOCKHOLM, April 03, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel ...